These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 30797859)

  • 1. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
    Adolph MB; Ara A; Chelico L
    J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
    Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein Interaction Map of APOBEC3 Enzyme Family Reveals Deamination-Independent Role in Cellular Function.
    Jang GM; Annan Sudarsan AK; Shayeganmehr A; Prando Munhoz E; Lao R; Gaba A; Granadillo Rodríguez M; Love RP; Polacco BJ; Zhou Y; Krogan NJ; Kaake RM; Chelico L
    Mol Cell Proteomics; 2024 May; 23(5):100755. PubMed ID: 38548018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles.
    Ajoge HO; Renner TM; Bélanger K; Greig M; Dankar S; Kohio HP; Coleman MD; Ndashimye E; Arts EJ; Langlois MA; Barr SD
    Nat Commun; 2023 Jan; 14(1):16. PubMed ID: 36627271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms.
    Ara A; Love RP; Chelico L
    PLoS Pathog; 2014 Mar; 10(3):e1004024. PubMed ID: 24651717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retroviral restriction factor APOBEC3G delays the initiation of DNA synthesis by HIV-1 reverse transcriptase.
    Adolph MB; Webb J; Chelico L
    PLoS One; 2013; 8(5):e64196. PubMed ID: 23717565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
    Refsland EW; Hultquist JF; Harris RS
    PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of HIV-1 infection by APOBEC3 proteins in primary human CD4(+) T cells is associated with inhibition of processive reverse transcription as well as excessive cytidine deamination.
    Gillick K; Pollpeter D; Phalora P; Kim EY; Wolinsky SM; Malim MH
    J Virol; 2013 Feb; 87(3):1508-17. PubMed ID: 23152537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flexibility in Nucleic Acid Binding Is Central to APOBEC3H Antiviral Activity.
    Bohn JA; DaSilva J; Kharytonchyk S; Mercedes M; Vosters J; Telesnitsky A; Hatziioannou T; Smith JL
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of the cytidine deaminase APOBEC3F have different HIV-1 restriction efficiencies.
    Mohammadzadeh N; Follack TB; Love RP; Stewart K; Sanche S; Chelico L
    Virology; 2019 Jan; 527():21-31. PubMed ID: 30448640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational comparison of the single-domained APOBEC3C and double-domained APOBEC3F/G anti-retroviral cytidine deaminases provides insight into their DNA target site specificities.
    Langlois MA; Beale RC; Conticello SG; Neuberger MS
    Nucleic Acids Res; 2005; 33(6):1913-23. PubMed ID: 15809227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible footprints of APOBEC3F and/or other APOBEC3 deaminases, but not APOBEC3G, on HIV-1 from patients with acute/early and chronic infections.
    Armitage AE; Deforche K; Welch JJ; Van Laethem K; Camacho R; Rambaut A; Iversen AK
    J Virol; 2014 Nov; 88(21):12882-94. PubMed ID: 25165112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of APOBEC3F in the Presence of the APOBEC3 Antagonist HIV-1 Vif Increases at the Expense of Co-Expressed APOBEC3H Haplotype I.
    Yousefi M; Annan Sudarsan AK; Gaba A; Chelico L
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
    Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
    Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dimerization regulates both deaminase-dependent and deaminase-independent HIV-1 restriction by APOBEC3G.
    Morse M; Huo R; Feng Y; Rouzina I; Chelico L; Williams MC
    Nat Commun; 2017 Sep; 8(1):597. PubMed ID: 28928403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligomerization transforms human APOBEC3G from an efficient enzyme to a slowly dissociating nucleic acid-binding protein.
    Chaurasiya KR; McCauley MJ; Wang W; Qualley DF; Wu T; Kitamura S; Geertsema H; Chan DS; Hertz A; Iwatani Y; Levin JG; Musier-Forsyth K; Rouzina I; Williams MC
    Nat Chem; 2014 Jan; 6(1):28-33. PubMed ID: 24345943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaminase-Dead Mouse APOBEC3 Is an
    Stavrou S; Zhao W; Blouch K; Ross SR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
    Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
    J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B: modern concepts in pathogenesis--APOBEC3 cytidine deaminases as effectors in innate immunity against the hepatitis B virus.
    Bonvin M; Greeve J
    Curr Opin Infect Dis; 2008 Jun; 21(3):298-303. PubMed ID: 18448976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.